Cargando…

PITX2 methylation: a novel and effective biomarker for monitoring biochemical recurrence risk of prostate cancer

AIMS: Prostate cancer is one of the most common malignancies in men. Biochemical recurrence (BCR) and progression following curative treatment pose a significant public health challenge. Thus, it is essential to explore effective biomarkers for disease progression monitoring and risk stratification....

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Qi, Xie, Mixue, He, Mengye, Yan, Feifei, Chen, Ming, Xu, Suzhen, Zhang, Xiaochen, Shen, Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6344153/ https://www.ncbi.nlm.nih.gov/pubmed/30608394 http://dx.doi.org/10.1097/MD.0000000000013820

Ejemplares similares

Anti-PD-1/PD-L1 antibodies versus docetaxel in patients with previously treated non-small-cell lung cancer
por: Jiang, Qi, et al.
Publicado: (2017)

PITX3 promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients after radical prostatectomy
por: Holmes, Emily Eva, et al.
Publicado: (2016)

Ability of PITX2 methylation to predict survival in patients with prostate cancer
por: Li, Jiu-zhi, et al.
Publicado: (2015)

Distinctive features of immunostaining and mutational load in primary pulmonary enteric adenocarcinoma: implications for differential diagnosis and immunotherapy
por: Chen, Ming, et al.
Publicado: (2018)

The PITX gene family as potential biomarkers and therapeutic targets in lung adenocarcinoma
por: Zhang, Chunyi, et al.
Publicado: (2021)

Association Between rs2200733 Polymorphism of PITX2 Gene and the Risk of Atrial Fibrillation
por: Shen Han, Yin, et al.
Publicado: (2023)

Clinical performance validation of PITX2 DNA methylation as prognostic biomarker in patients with head and neck squamous cell carcinoma
por: Sailer, Verena, et al.
Publicado: (2017)

PITX1 Is a Regulator of TERT Expression in Prostate Cancer with Prognostic Power
por: Poos, Alexandra M., et al.
Publicado: (2022)

Abnormal PITX1 gene methylation in adolescent idiopathic scoliosis: a pilot study
por: Shi, Benlong, et al.
Publicado: (2018)

DNA methylation pattern of the goat PITX1 gene and its effects on milk performance
por: Zhao, Haiyu, et al.
Publicado: (2019)

The expression and methylation of PITX genes is associated with the prognosis of head and neck squamous cell carcinoma
por: Zhao, Yaqiong, et al.
Publicado: (2022)

Identification of tumor-agnostic biomarkers for predicting prostate cancer progression and biochemical recurrence
por: Lautert-Dutra, William, et al.
Publicado: (2023)

Association of molecular biomarkers expression with biochemical recurrence in prostate cancer through tissue microarray immunostaining
por: MA, DING, et al.
Publicado: (2015)

Pitx2 in Embryonic and Adult Myogenesis
por: Hernandez-Torres, Francisco, et al.
Publicado: (2017)

Sporoderm-Broken Spores of Ganoderma lucidum Sensitizes Ovarian Cancer to Cisplatin by ROS/ERK Signaling and Attenuates Chemotherapy-Related Toxicity
por: Cen, Kaili, et al.
Publicado: (2022)

PITX1 is a reliable biomarker for predicting prognosis in patients with oral epithelial dysplasia
por: NAKABAYASHI, MOTOKI, et al.
Publicado: (2014)

A PITX2 splice-site mutation in a family with Axenfeld-Rieger syndrome leads to decreased expression of nuclear PITX2 protein
por: Zhang, Feng, et al.
Publicado: (2021)

Prostate Region-Wise Imaging Biomarker Profiles for Risk Stratification and Biochemical Recurrence Prediction
por: Sánchez Iglesias, Ángel, et al.
Publicado: (2023)

Construction of DNA methylation-based nomogram for predicting biochemical-recurrence-free survival in prostate cancer
por: Zhu, Jiayu, et al.
Publicado: (2022)

PITX1 plays essential functions in cancer
por: Zhao, Jingpu, et al.
Publicado: (2023)

PD-L1 promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients following radical prostatectomy
por: Gevensleben, Heidrun, et al.
Publicado: (2016)

Assessment of biochemical recurrence of prostate cancer (Review)
por: Lin, Xiaozeng, et al.
Publicado: (2019)

DNA Methylation of PITX2 and PANCR Is Prognostic for Overall Survival in Patients with Resected Adenocarcinomas of the Biliary Tract
por: Uhl, Barbara, et al.
Publicado: (2016)

Promoter Methylation of Protocadherin8 is an Independent Prognostic Factor for Biochemical Recurrence of Early-Stage Prostate Cancer
por: Niu, Wen-Bin, et al.
Publicado: (2014)

Aberrant Methylation of PCDH10 Predicts Worse Biochemical Recurrence-Free Survival in Patients with Prostate Cancer After Radical Prostatectomy
por: Wang, Li, et al.
Publicado: (2014)

Management of biochemical recurrence after radical prostatectomy for prostate cancer: A case report
por: Shen, Jiayan, et al.
Publicado: (2019)

Transgenic Insights Linking Pitx2 and Atrial Arrhythmias
por: Franco, Diego, et al.
Publicado: (2012)

Multiple Roles of Pitx2 in Cardiac Development and Disease
por: Franco, Diego, et al.
Publicado: (2017)

PITX3 DNA methylation is an independent predictor of overall survival in patients with head and neck squamous cell carcinoma
por: Sailer, Verena, et al.
Publicado: (2017)

PITX2 and PANCR DNA methylation predicts overall survival in patients with head and neck squamous cell carcinoma
por: Sailer, Verena, et al.
Publicado: (2016)

Identification of genes that predict the biochemical recurrence of prostate cancer
por: Chu, Jianfeng, et al.
Publicado: (2018)

UDP-glucuronosyltransferases and biochemical recurrence in prostate cancer progression
por: Grant, Delores J., et al.
Publicado: (2017)

Predicting biochemical recurrence of prostate cancer with artificial intelligence
por: Pinckaers, Hans, et al.
Publicado: (2022)

Identification of Potential Predictor of Biochemical Recurrence in Prostate Cancer
por: Wei, Jingchao, et al.
Publicado: (2022)

Identification of microenvironment related potential biomarkers of biochemical recurrence at 3 years after prostatectomy in prostate adenocarcinoma
por: Sun, Xiaoru, et al.
Publicado: (2021)

Mitochondrial Aldehyde Dehydrogenase 2 Represents a Potential Biomarker of Biochemical Recurrence in Prostate Cancer Patients
por: Feng, Dechao, et al.
Publicado: (2022)

Identification of a prognostic biomarker predicting biochemical recurrence and construction of a novel nomogram for prostate cancer
por: Yu, Zhaojun, et al.
Publicado: (2023)

Promoter Methylation of PRKCB, ADAMTS12, and NAALAD2 Is Specific to Prostate Cancer and Predicts Biochemical Disease Recurrence
por: Daniunaite, Kristina, et al.
Publicado: (2021)

Association of PTEN expression with biochemical recurrence in prostate cancer: results based on previous reports
por: Xie, Haijie, et al.
Publicado: (2017)

Anterior segment mesenchymal dysgenesis in a large Australian family is associated with the recurrent 17 bp duplication in PITX3
por: Summers, Kim M., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_jqf46gik04aerbk8nj84ol6li4